Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 305 of 305 entries
View as:

Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients

Phase: N/A Priority: Normal
NCT ID: NCT04418401 Org: User:
Start: 06/11/20 End: 06/01/24 Due: 06/01/25

Artificially Intelligent Model for Accurate Detection of HCC

Phase: N/A Priority: Normal
NCT ID: NCT06637059 Org: User:
Start: 01/01/24 End: 10/01/24 Due: 10/01/25

CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04609241 Org: User:
Start: 11/15/20 End: 11/15/26 Due: 11/15/27

Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06995105 Org: User:
Start: 04/09/25 End: 04/01/28 Due: 04/01/29

Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05233917 Org: User:
Start: 06/09/23 End: 12/22/23 Due: 12/22/24